David Corcoran, DPM
Primary Podiatric Medicine · Phoenix, AZNPI 1528026044
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Medline Industries LP at 52.3% of the total. Reporting peaked in 2024 at $2,131 and has fallen 73.5% since, to $564 in 2025.
Across 48 payments — averaging $82.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medline Industries LP$2K
- Vilex LLC$773
- Forthright Medical - AZ, LLC$387
- Cardiovascular Systems Inc.$146
- Ortho Systems$107
- Amgen$90
- plus $391 from 17 others
What the payments were for
- Travel & lodging$2,20456%
- Food & beverage$1,65642%
- Education$1073%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medline Industries LP | 12 | $2,073 |
| Vilex LLC | 3 | $773 |
| Forthright Medical - AZ, LLC | 5 | $387 |
| Cardiovascular Systems Inc. | 1 | $146 |
| Ortho Systems | 1 | $107 |
| Amgen(2 entities) | 5 | $90 |
| Medtronic | 1 | $82 |
| Integra Lifesciences Corporation | 2 | $48 |
| Smith+Nephew | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| Nevro Corp. | 1 | $25 |
| Advanced Oxygen Therapy Inc. | 2 | $24 |
| Orthofix Medical, Inc. | 1 | $16 |
| Arthrosurface Incorporated | 1 | $15 |
| Organogenesis Inc. | 1 | $15 |
| Abbott | 1 | $15 |
| Bioventus LLC | 1 | $14 |
| Flower Orthopedics Coporation | 1 | $14 |
| Merck | 1 | $14 |
| Melinta Therapeutics, LLC | 1 | $12 |
| Aap Implants Inc | 1 | $11 |
| Reprise Biomedical, Inc. | 1 | $10 |
| Biocomposites Inc | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REDEMPTION$660
- OSSIOFIBER COMPRESSION STAPLE SYSTEM$349
- Peripheral Orbital Atherectomy System$146
How this compares
Too few primary podiatric medicine providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 38 | $1,370 |
| Cephalexin | 31 | $320 |
| SsdSilver Sulfadiazine | 16 | $234 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $216 |
| Silver Sulfadiazine | 12 | $120 |
| Amoxicillin | 15 | $25 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Phoenix
- Warren JosephPhoenix$529K
- Stephen GellerPhoenix$78
- Zeno PfauTucson$5K
- Naresh DugalScottsdale$3K
- Ronaldo HolgadoSurprise$2K
- Brian HutchesonTucson$902
- Ruth KosakScottsdale$333
- Jean KroynCottonwood$306
- Phillip TutnauerPinon$36
- Sanford KanerSurprise$20
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.